Deregulation of the Rb and p53 pathways in uveal melanoma

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 1795-1801

  Brantley M A , Jr ^a   Harbour, J W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; DEREGULATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR BIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX RATIO; TREATMENT FAILURE; TUMOR VOLUME; UVEA MELANOMA;

EID: 0033637120     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9440(10)64817-1     Document Type: Article

References (46)

1. DePinho RA: Malignant melanoma: Modern black plague and genetic black box
2. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation
3. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
4. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization
5. Genetic aspects of uveal melanoma: A brief review
6. Constitutional alterations in p16 in patients with uveal melanoma
7. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes
8. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
9. Cancer cell cycles
10. The p53 pathway
11. The hallmarks of cancer
12. The retinoblastoma protein pathway in cell cycle control and cancer
13. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
14. Structural evidence for the authenticity of the human retinoblastoma gene
15. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
16. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
17. Inactivation of Rb in uveal melanoma by phosphorylation of sites in the C-terminal region
18. p53, the cellular gatekeeper for growth and division
19. p53-dependent apoptosis suppresses tumor growth and progression in vivo
20. Increased expression and mutation of p53 in choroidal melanoma
21. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
22. p53 gene and cell cycling in uveal melanoma
23. Alcoholic liver disease: I. Interrelationships among histologic features and the histologic effects of prednisolone therapy
24. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma
25. Signaling to p53: Breaking the MDM2-p53 circuit
26. A cell cycle regulator potentially involved in genesis of many tumor types
27. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma
28. Prognostic parameters in uveal melanoma: A review
29. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma
30. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
31. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points
32. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
33. The prognostic significance of c-myc oncogene expression in uveal melanoma
34. C-myc oncogene expression in ocular melanomas
35. Clinical implications of the p53 tumor-suppressor gene
36. TP53 allele loss, mutations and expression in malignant melanoma
37. Mdm2 promotes the rapid degradation of p53
38. MDM2 gene amplification and transcript levels in human sarcomas: Relationship to TP53 gene status
39. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma
40. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein
41. BCL-2 family members and the mitochondria in apoptosis
42. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
43. The relationship between Bcl2, Bax and p53: Consequences for cell cycle progression and cell death
44. Expression of bcl-2 in uveal malignant melanoma
45. Malignant melanoma arising from nevi, p53, p16, and Bcl-2: Expression in benign versus malignant components
46. Rb function in cell-cycle regulation and apoptosis